April 7 (Reuters) – Valeant Pharmaceuticals International Inc said on Thursday it had won approval from its lenders for an amendment and waiver to its credit facility, giving the embattled drugmaker…
The post UPDATE 1-Valeant gets extra month from lenders to file annual report appeared first on NASDAQ.